Prevalence of neuropsychiatric adverse events and associated factors among adult patients on dolutegravir attending Mulago <scp>ISS</scp> clinic-Reference-Cited by-同舟云学术

Prevalence of neuropsychiatric adverse events and associated factors among adult patients on dolutegravir attending Mulago ISS clinic

Published:2022-11-06 Issue:4 Volume:24 Page:491-501
ISSN:1464-2662
Container-title:HIV Medicine
language:en
Short-container-title:HIV Medicine

Author:

Mwebaza Joyce¹,Meya David²,Musiime Victor³,Birungi Caroline⁴

Affiliation:

1. MU‐JHU Research Collaboration Kampala Uganda

2. Internal Medicine Department, College of Health Sciences Makerere University Kampala Uganda

3. Pediatrics and Child Health Department, College of Health Sciences Makerere University Kampala Uganda

4. Psychiatry Department, College of Health Sciences Makerere University Kampala Uganda

Publisher

Wiley

Subject

Pharmacology (medical),Infectious Diseases,Health Policy

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/hiv.13428

Reference24 articles.

1. WHOImplementation tool for monitoring the toxicity of new antiretroviral medicines in HIV and viral hepatitis programmes.(2018b).

2. WHO. (2019).Dolutegravir as preferred HIV treatment option in all populations.https://www.who.int/news/item/22-07-2019-who-recommends-dolutegravir-as-preferred-hiv-treatment-option-in-all-populations

3. Dolutegravir and central nervous system side‐effects: abacavir, older age increase the risk;Quercia R;HIV Glasgow,2016

4. Dolutegravir based antiretroviral therapy compared to other combined antiretroviral regimens for the treatment of HIV-infected naive patients: A systematic review and meta-analysis

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Neuropsychiatric Adverse Events Following Antiretroviral Therapy in People Living with HIV: A Real-World Study of Dynamic Trends and Risk Factors in Hangzhou, China;Infection and Drug Resistance;2023-08